MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-11-2026
Country |
 USA |
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
1.46 M |
Market Cap[1] |
$ 19.4 M |
EBITDA (LTM) |
$ -13.7 M |
P/E (LTM) |
- |
P/S (LTM) |
168.58 |
EPS (LTM) |
-5.43 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
$ 115.35 | -2.33 % | $ 35.1 B | NYSE,SPB | USA |
 |
Anixa Biosciences
ANIX
|
$ 2.81 | -2.7 % | $ 91.2 K | Nasdaq Capital Market | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 22.48 | -1.58 % | $ 234 M | Nasdaq Global Market |  China |
 |
Bioventus
BVS
|
$ 8.45 | -7.14 % | $ 563 M | Nasdaq Global Select Market | USA |
 |
Celcuity
CELC
|
$ 114.85 | -0.34 % | $ 4.53 B | Nasdaq Global Select Market | USA |
 |
Castle Biosciences
CSTL
|
$ 27.23 | -2.44 % | $ 756 M | Nasdaq Global Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 175.23 | -3.37 % | $ 8.69 B | NYSE,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | USA |
 |
Fulgent Genetics
FLGT
|
$ 14.59 | 2.41 % | $ 441 M | Nasdaq Global Market | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
|
Biodesix
BDSX
|
$ 18.61 | 17.37 % | $ 2.41 B | Nasdaq Global Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Illumina
ILMN
|
$ 124.76 | -2.71 % | $ 19.8 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 175.33 | -1.8 % | $ 30.1 B | NYSE,SPB | USA |
 |
BioNano Genomics
BNGO
|
$ 1.11 | -1.36 % | $ 1.41 M | Nasdaq Capital Market,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 199.8 | -2.07 % | $ 22.2 B | NYSE,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 195.75 | -2.99 % | $ 140 B | NYSE,SPB | USA |
 |
IDEXX Laboratories
IDXX
|
$ 607.19 | -1.9 % | $ 48.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 103.5 | 0.17 % | $ 19.5 B | Nasdaq Capital Market,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 9.69 | -3.0 % | $ 275 M | Nasdaq Capital Market |  Israel |
 |
Laboratory Corporation of America Holdings
LH
|
$ 269.52 | -2.34 % | $ 22.4 B | NYSE,SPB | USA |
 |
DexCom
DXCM
|
$ 68.5 | -3.1 % | $ 26.7 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
ICON Public Limited Company
ICLR
|
$ 107.08 | -3.19 % | $ 8.83 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Lantheus Holdings
LNTH
|
$ 72.86 | -4.53 % | $ 4.92 B | Nasdaq Global Select Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 17.91 | -4.48 % | $ 954 M | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 215.85 | -3.66 % | $ 25.1 B | NYSE,SPB |  Schweiz |
 |
Myriad Genetics
MYGN
|
$ 5.15 | 0.29 % | $ 477 M | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 8.92 | -2.3 % | $ 1.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
National Research Corporation
NRC
|
$ 14.48 | 3.13 % | $ 324 M | Nasdaq Global Select Market | USA |
 |
Guardant Health
GH
|
$ 91.56 | -1.1 % | $ 11.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Natera
NTRA
|
$ 196.94 | -0.1 % | $ 19.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Brainsway Ltd.
BWAY
|
$ 12.28 | -2.69 % | $ 99.4 M | Nasdaq Global Select Market | Israel |
 |
OPKO Health
OPK
|
$ 1.18 | 0.43 % | $ 819 M | Nasdaq Global Select Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.